Effectiveness and Predictors of Response to Somatostatin Analogues in GI Angiodysplasias
Goltstein LCMJ, Grooteman KV, Rocco A, et al.
Lancet Gastroenterology and Hepatology. 2021
Individual patient data meta-analysis supporting octreotide LAR; 82% transfusion reduction
Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia
Chen H, Wu S, Tang M, et al.
New England Journal of Medicine. 2023
Landmark RCT demonstrating thalidomide efficacy vs. placebo for refractory small bowel angiodysplasia
Advances in the Management of Lower Gastrointestinal Bleeding
Alali AA, Almadi MA, Barkun AN.
Alimentary Pharmacology and Therapeutics. 2024
Comprehensive review including angiodysplasia management algorithms
The Role of Imaging for Gastrointestinal Bleeding: Consensus Recommendations
Sengupta N, Kastenberg DM, Bruining DH, et al.
American Journal of Gastroenterology. 2024
ACG and Society of Abdominal Radiology joint consensus on imaging
Recent Advances in the Treatment of Refractory GI Angiodysplasia
Becq A, Sidhu R, Goltstein LCMJ, Dray X.
United European Gastroenterology Journal. 2024
Emerging therapies including thalidomide, bevacizumab, pomalidomide
Acute Lower Gastrointestinal Bleeding
Gralnek IM, Neeman Z, Strate LL.
New England Journal of Medicine. 2017
Classic review of LGIB epidemiology, diagnosis, and management
AGA Clinical Practice Update on Management of Iron Deficiency Anemia
DeLoughery TG, Jackson CS, Ko CW, Rockey DC.
Clinical Gastroenterology and Hepatology. 2024
Iron replacement strategies including IV iron protocols
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.